Panel 4: Precision Medicine – The New Frontier
Hailed as the next big wave of breakthroughs in biotechnology, precision medicine has captured the imagination of patients, physicians, researchers, businesses, and even the White House, with California leading the charge. This panel will discuss the trends, opportunities, and barriers in advancing a field that has already begun to revolutionize healthcare.
Executive Director, Corporate Strategy
Senior Director Software Engineering and Bioinformatics, Oncology
Vice President, Finance
Dr. Daniel Geschwind
UCLA Institute for Precision Health
David J. Whelan